Found: 6
Select item for more details and to access through your institution.
QcrC is a potential target for antibody therapy and vaccination to control Campylobacter jejuni infection by suppressing its energy metabolism.
- Published in:
- Frontiers in Microbiology, 2024, p. 01, doi. 10.3389/fmicb.2024.1415893
- By:
- Publication type:
- Article
Adjuvant Activity of Synthetic Lipid A of Alcaligenes, a Gut-Associated Lymphoid Tissue-Resident Commensal Bacterium, to Augment Antigen-Specific IgG and Th17 Responses in Systemic Vaccine.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 395, doi. 10.3390/vaccines8030395
- By:
- Publication type:
- Article
Chemically Synthesized Alcaligenes Lipid A as an Adjuvant to Augment Immune Responses to Haemophilus Influenzae Type B Conjugate Vaccine.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.763657
- By:
- Publication type:
- Article
Chemically Synthesized Alcaligenes Lipid A Shows a Potent and Safe Nasal Vaccine Adjuvant Activity for the Induction of Streptococcuspneumoniae-Specific IgA and Th17 Mediated Protective Immunity.
- Published in:
- Microorganisms, 2020, v. 8, n. 8, p. 1102, doi. 10.3390/microorganisms8081102
- By:
- Publication type:
- Article
Lipopolysaccharide Derived From the Lymphoid-Resident Commensal Bacteria Alcaligenes faecalis Functions as an Effective Nasal Adjuvant to Augment IgA Antibody and Th17 Cell Responses.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.699349
- By:
- Publication type:
- Article
Alcaligenes lipid A functions as a superior mucosal adjuvant to monophosphoryl lipid A via the recruitment and activation of CD11b<sup>+</sup> dendritic cells in nasal tissue.
- Published in:
- International Immunology, 2024, v. 36, n. 1, p. 33, doi. 10.1093/intimm/dxad045
- By:
- Publication type:
- Article